Quarterly ResultAug 6, 2026, 07:27 AM
Sotera Health Q2 Net Income $54M; Raises FY26 Outlook
AI Summary
Sotera Health Company reported strong second-quarter 2026 financial results, with net income rising to $54 million, or $0.19 per diluted share, compared to $8 million, or $0.03 per diluted share in Q2 2025. Net revenues increased 9.2% to $321.375 million. The company also raised its full-year 2026 outlook for both net revenues and Adjusted EBITDA growth, citing strong first-half performance and confidence in the remainder of the year.
Key Highlights
- Q2 2026 net revenues increased 9.2% to $321.375 million (8.0% constant currency).
- Q2 2026 net income was $54 million, up from $8 million in Q2 2025.
- Q2 2026 Adjusted EPS rose 30% to $0.26 per diluted share.
- Raised full-year 2026 net revenues growth outlook to 5.25% - 6.75% (constant currency).
- Raised full-year 2026 Adjusted EBITDA growth outlook to 5.75% - 7.25% (constant currency).
- Achieved long-term Net Leverage Ratio target of 3.0x as of June 30, 2026.
- Sterigenics segment revenue grew 7.0% constant currency in Q2 2026.
- Nordion segment revenue grew 16.7% constant currency in Q2 2026.
Price Impact
More from SHC